Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gallbladder Neoplasms × Peripheral Blood Stem Cell Transplantation × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 54 Multiple Myeloma 53 Hodgkin Disease 51 Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Lymphoma, Non-Hodgkin 46 Leukemia, Lymphocytic, Chronic, B-Cell 44 Myelodysplastic Syndromes 41 Lymphoma, Mantle-Cell 39 Lymphoma, Large B-Cell, Diffuse 38 Lymphoma, Follicular 36 Leukemia 36 Congenital Abnormalities 36 Burkitt Lymphoma 34 Myeloproliferative Disorders 31 Lymphoma 30 Lymphoma, B-Cell, Marginal Zone 29 Lymphoma, Large-Cell, Immunoblastic 28 Leukemia, Myeloid, Chronic-Phase 26 Leukemia, Myeloid, Accelerated Phase 26 Waldenstrom Macroglobulinemia 25 Leukemia, Myelomonocytic, Chronic 24 Blast Crisis 24 Recurrence 19 Primary Myelofibrosis 19 Lymphoma, T-Cell, Cutaneous 19 Neoplasms, Plasma Cell 18 Lymphoma, Large-Cell, Anaplastic 18 Myelodysplastic-Myeloproliferative Diseases 16 Sezary Syndrome 15 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15

Interventions

Gemcitabine 18 Cisplatin 10 Capecitabine 9 Oxaliplatin 6 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Erlotinib Hydrochloride 3 trifluridine tipiracil drug combination 2 regorafenib 2 cobimetinib 2 atezolizumab 2 Trastuzumab 2 Taxes 2 Specimen Handling 2 Platinum 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Lapatinib 2 Biopsy 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 varlilumab 1 vandetanib 1 tucatinib 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡